Results 71 to 80 of about 1,330 (154)

Monitoring the efficiency of reversal on anti-Xa direct oral anticoagulants using point-of-care viscoelastic testing

Thrombosis Journal
Bleeding events in patients receiving direct oral anticoagulation (DOAC) can be life-threatening even at therapeutic DOAC plasma concentrations, as anticoagulation impairs hemostasis and should therefore be identified immediately after hospital admission.
Lars Heubner, Oliver Grottke, Oliver Vicent, Peter Markus Spieth, Jan Beyer-Westendorf   +4 more
doaj   +1 more source

Andexanet alfa—The first 150 days [PDF]

American Journal of Hematology, 2018
Sarah E. Culbreth, Jessica Rimsans, Katelyn Sylvester, Daniel J. Pallin, Jean M. Connors   +4 more
openaire   +2 more sources

Targeted anticoagulant reversal, unintended consequences: lessons from andexanet alfa. [PDF]

Eur Heart J Cardiovasc Pharmacother
Levy JH, Shaw JR.
europepmc   +1 more source

Emergency reversal of Rivaroxaban with Andexanet alfa in a child with hemorrhagic brain metastasis from Wilms tumor. [PDF]

Childs Nerv Syst
Rafaelian A, Won SY, Mueller L, Armbrust M, Weber KJ, Haas A, Reuter DA, Freiman TM, Gessler F, Spang C, Meyer-Bahlburg A, Hingst P, Classen CF, Dubinski D, Cardesa-Salzmann TM.   +14 more
europepmc   +1 more source

Coordinating emergent procedures after andexanet alfa [PDF]

American Journal of Hematology, 2019
Sarah E. Culbreth, Katelyn W. Sylvester, Jessica Rimsans, Jean M. Connors   +3 more
openaire   +2 more sources

TFPIα inhibition by andexanet alfa is partially restored by protein S and factor V-short. [PDF]

Blood Adv
Crossette-Thambiah C, Bamberg K, Laffan M, Ahnström J.   +3 more
europepmc   +1 more source

Andexanet Alfa for Life-Threatening Bleeding Following Factor Xa Inhibitor Treatment: Postmarketing Surveillance Study in Japan. [PDF]

JACC Asia
Sakamoto K, Ishihara M, Kato H, Kim H, Okuda M, Hiroki S, Koga M, Toyoda K.   +7 more
europepmc   +1 more source

Successful use of an antithrombin for heparin resistance with andexanet alfa. [PDF]

JA Clin Rep, 2023
Honda J, Itakura Y, Tanaka S, Inoue S.
europepmc   +1 more source

Andexanet Alfa in Emergency Cranial Neurosurgical Procedures: A Bicentric Analysis of Efficacy and Safety. [PDF]

Neurocrit Care
Hounchonou HF, Albrecht C, Jelinek J, Wild F, Polemikos M, Abu-Fares O, Negwer C, Meyer B, Al-Afif S, Krauss JK.   +9 more
europepmc   +1 more source

Successful Nafamostat Mesilate Administration for Andexanet Alfa-Induced Heparin Resistance. [PDF]

Cureus, 2023
Kitaura A, Iwamoto T, Hamasaki S, Tsukimoto S, Nakajima Y.   +4 more
europepmc   +1 more source